Premium
Day case discharge of patients treated with drug coated balloon only angioplasty for de novo coronary artery disease: A single center experience
Author(s) -
Merinopoulos Ioannis,
Wickramarachchi Upul,
Wardley James,
Khanna Vikram,
Gunawardena Tharusha,
Maart Clint,
Vassiliou Vassilios S.,
Eccleshall Simon C.
Publication year - 2020
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.28217
Subject(s) - medicine , angioplasty , balloon , coronary artery disease , surgery , retrospective cohort study , single center , cardiology
Objective To report our initial experience with drug coated balloon (DCB) only angioplasty and propose a protocol to achieve this safely. Background There are no articles published in the literature currently regarding the safety of same day discharge in patients treated with DCB‐only angioplasty. Methods Retrospective review of all our patients treated with DCB‐only angioplasty from September 2017 to April 2018 with identification of potential complications relating to same day discharge. Results A total of 100 consecutive patients who underwent elective DCB‐only angioplasty for de novo coronary artery disease and were discharged on the same day as the procedure were included. In 99% no cardiac symptoms relating to the procedure requiring urgent hospitalization or urgent investigations were identified. One patient was readmitted the next day requiring stenting of the previously treated lesion. Our 30‐day mortality was zero. Some 97 hospital bed days were saved with 100 patients treated. Conclusion Elective day‐case DCB‐only angioplasty according to our local protocol is safe and cost‐effective and should be considered for the majority of the patients.